Join The Discussion

 

RadioShack sees stock jump on investment report

Fort Worth-based RadioShack saw its stock increase as much as 45 percent on Friday as investor Standard General LP said it was continuing talks on new financing for the electronics retailer.

read more >

Fort Worth couple gets in 'Shark Tank,' comes out with deal

A Fort Worth couple who started a business when they couldn’t sleep, were the first entrepreneurs to get a deal on ABC’s Shark Tank in the season premiere on Sept. 26.

read more >

20 from Dallas-Fort Worth on Forbes wealthiest list

There are 20 Dallas-Fort Worth residents listed among the 400 richest Americans, according to the Forbes 400 list of The Richest People in America 2014.

read more >

Internal audit says EPA mismanaged Fort Worth project

FORT WORTH, Texas (AP) — An internal audit by the U.S. Environmental Protection Agency reveals the agency mismanaged an experiment using new ways to demolish asbestos-ridden buildings.

read more >

Texas Wesleyan acquires two strip shopping centers on East Rosedale

Texas Wesleyan University has purchased two strip shopping centers on East Rosedale Street across from its Southeast Fort Worth campus, the university’s president said Friday.

read more >

TECH Fort Worth client receives $550,000 financing

 

Betty Dillard

bdillard@bizpress.net

Vital Art and Science Inc. (VAS), creator of the myVisionTrack home vision monitor, has completed a $550,000 Series A round of financing, the Richardson-based company announced Aug. 27.


The funding will enable VAS to continue development of its smart phone-based home monitor products and support its work with strategic partners to bring the myVisionTrack test to millions of patients around the world.
The funding round was led by the North Texas Angel Network (NTAN), and valued the company at $10 million post financing.


“The myVisionTrack home monitor is the first easy-to-use and accurate test for patients already diagnosed with a wet-AMD, or diabetic retinopathy, to monitor their disease progress and help ensure they get timely treatments to help save their vision,” said Mike Bartlett, VAS founder and president.


Bartlett said the company received its clearance from the U.S. Food and Drug Administration in February. The funding will allow VAS, a client of technology incubator TECH Fort Worth, to bring its product to market.
MyVisionTrack can be used in a physician’s office or at home by patients with these diseases to help track disease progression, detect disease condition changes for earlier intervention and document treatment effects.
 

< back

Email   email
hide
Arena
What do you think of the new plans for a new Will Rogers arena and changes at the Convention Center?